Good future awaits

Onyx Scientific continues to grow after the downturn that affected the whole sector in 2009-10. The company is now in it's 12th year of supplying top quality services and is gearing up for another decade of growth. We are looking for new companies to serve and invite new enquiries and enquirers.

Potentially better regulatory environment for antibiotic development

The UK Office of Health Economics is recommending to the EU swifter reviews of antibiotics by regulatory agencies. The proposals are aimed at encouraging the development of new antibiotics & improve R&D returns. Lets hope that this has a positive effect.